Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (131-140 of 381) with videos related to

Pageof 39
Sort By:
Current Drug Safety|January 20, 2019
Aripiprazole Overdose and Transient 2:1 Second Degree Atrioventricular Block: Only A Coincidence?Lucia Russo, Angelo Di Vincenzo, Alessandro Rizzo, et al.
Future Oncology (London, England)|December 20, 2021
Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trialsAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Expert Review of Gastroenterology & Hepatology|March 31, 2021
FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issueAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
Clinical Nutrition ESPEN|March 29, 2025
Prognostic significance of the cachexia index (CXI) in patients with cancer: A systematic review and meta-analysisOnur Bas, Taha Koray Sahin, Latif Karahan, et al.
Nature Reviews. Urology|November 22, 2022
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinomaMatteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
Proceedings. Mathematical, Physical, and Engineering Sciences|February 22, 2020
Leader-follower consensus on activity-driven networksJalil Hasanyan, Lorenzo Zino, Daniel Alberto Burbano Lombana, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic ChallengesAlessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, et al.
Expert Review of Clinical Pharmacology|February 16, 2023
Prostate cancer and novel pharmacological treatment options-what's new for 2022?Andrea Marchetti, Elisa Tassinari, Matteo Rosellini, et al.
Scientific Reports|February 7, 2018
Epidemic spreading in modular time-varying networksMatthieu Nadini, Kaiyuan Sun, Enrico Ubaldi, et al.
Expert Review of Molecular Diagnostics|March 23, 2026
Artificial intelligence in cancer screening: a narrative review of current evidence and future directionsYigit Yazarkan, Gamze Sonmez, Taha Koray Sahin, et al.
Pageof 39

Showing results (131-140 of 381) with videos related to

Sort By:
Pageof 39
Current Drug Safety|January 20, 2019
Aripiprazole Overdose and Transient 2:1 Second Degree Atrioventricular Block: Only A Coincidence?Lucia Russo, Angelo Di Vincenzo, Alessandro Rizzo, et al.
Future Oncology (London, England)|December 20, 2021
Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trialsAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Expert Review of Gastroenterology & Hepatology|March 31, 2021
FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issueAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
Clinical Nutrition ESPEN|March 29, 2025
Prognostic significance of the cachexia index (CXI) in patients with cancer: A systematic review and meta-analysisOnur Bas, Taha Koray Sahin, Latif Karahan, et al.
Nature Reviews. Urology|November 22, 2022
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinomaMatteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
Proceedings. Mathematical, Physical, and Engineering Sciences|February 22, 2020
Leader-follower consensus on activity-driven networksJalil Hasanyan, Lorenzo Zino, Daniel Alberto Burbano Lombana, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic ChallengesAlessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, et al.
Expert Review of Clinical Pharmacology|February 16, 2023
Prostate cancer and novel pharmacological treatment options-what's new for 2022?Andrea Marchetti, Elisa Tassinari, Matteo Rosellini, et al.
Scientific Reports|February 7, 2018
Epidemic spreading in modular time-varying networksMatthieu Nadini, Kaiyuan Sun, Enrico Ubaldi, et al.
Expert Review of Molecular Diagnostics|March 23, 2026
Artificial intelligence in cancer screening: a narrative review of current evidence and future directionsYigit Yazarkan, Gamze Sonmez, Taha Koray Sahin, et al.
Pageof 39